Does it excite you to lead a team of highly skilled scientists and technicians? and do you have experience with metabolic health and bioinformatics? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
Your new position
As a leader for the In Vivo Pharmacology team, you will develop, guide and empower team members. The team consists of 5 scientists and 3 lab technicians. In addition, you will keep yourself sharp on science by contributing directly to our research projects with your scientific expertise.
We offer exciting responsibilities:
Leading and developing scientists and technicians.
Driving our projects forward in the role of ” Scientific Lead” supporting the project groups with high level science input.
Ensure and oversee the development of the models needed to drive our projects forward with efficiency and high quality.
Identify new potential drug targets and suggest new early research projects.
Building partnerships with academia and other potential collaborators.
Your profile
You are passionate about leading scientists and technicians where you use your empathy and solid communications skills to navigate the team through changes. With genuine interest in translational research focused on metabolic health, neuroscience, and obesity-related inflammation, you excel at building productive relationships across functions and levels.
Postdoc experience.
Experience with leading teams.
Experience in developing and running animal models within the metabolic neuroscience area (obesity and comorbidities).
Strong statistical analysis competencies.
An advantage with competencies within bioinformatics.
An advantage with knowledge within inflammation.
Confident in interpretation, reporting and publication of study results.
Your new team
The Translational Pharmacology function, is a part of Zealand Pharma’s Research organization that is responsible for identifying new drug targets and driving them forward to clinical trials. We are focused on delivering high quality drug candidates within the agreed time frame to our Clinical development organization.
The Translational Pharmacology function consists of 3 in vivo departments, counting 29 people in total, where you will lead one of them. You will be part of a leadership team consisting of 4 people.
Let’s bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let’s bond and be bold
Interested in bonding with us? Then please apply no later than November 30, 2025, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
For further information, please contact Head of Translational Pharmacology, Senior Director, Erik Max Wulff, [email protected]. We are committed to an inclusive recruitment process and welcome applications from all job applicants.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a team in the U.S. For more information about Zealand Pharma’s business and activities, please visit www.zealandpharma.com.
Top Skills
What We Do
Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines.
In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other.
This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases.
Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals.
Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn
